Clinical Trials Browser

OTHER × Lymphoma × avelumab × Clear all

NCT03636503 2025-02-06

Rituximab + Immunotherapy in Follicular Lymphoma

Phase 1 Terminated

24 enrolled 25 charts

Lymphoma, Lymphoma, Follicular

NCT03046953 2024-07-16

AVAIL-T

Phase 2 Completed

35 enrolled 21 charts

Lymphoma